Resistin, adiponectin and visfatin; can adipocytokines predict gestational diabetes mellitus and early post partum metabolic syndrome?

Iranian Journal of Diabetes and Lipid Disorders

Volumn 9, Issue , 2010, Pages

  Hossein nezhad, Arash ^a   Mirzaei, Khadijeh ^a   Maghbooli, Zhila ^a   Rahmani, Mazaher ^a   Larijani, Bagher ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adipokines; Adiponectin; Gestational diabetic mellitus; Metabolic syndrome; Resistin; Visfatin

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RESISTIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; PARITY; PREGNANCY DIABETES MELLITUS; STATISTICAL ANALYSIS;

EID: 78651225959     PISSN: 17267544     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Catalano, P.M., Hoegh, M., Minium, J. et al. Adiponectin in human pregnancy: implications for regulation of glucose and lipid metabolism. Diabetologia, 2006; 49: 1677-1685.
2. Maghbooli Z, Hossein-Nezhad A, Karimi F, Shafaei AR, Larijani B.Correlation between vitamin D3 deficiency and insulin resistance in pregnancy. Diabetes Metab Res Rev 2008; 24:27-32.
3. Hossein-Nezhad A, Maghbooli Z, Vassigh AR, Larijani B. Prevalence of gestational diabetes mellitus and pregnancy outcomes in Iranian women. Taiwan J Obstet Gynecol 2007; 46(3):236-41.
4. Hadden, D.R., Geographic, ethnic and racial variations in the incidence of gestational diabetes mellitus. Diabetes 1985; 34: 8-12.
5. Metzger, B.E., Cho, N.H., Roston, S.M., Radvany, R., Pre-pregnancy weight and antepartum insulin secretion predict glucose tolerance five years after gestational diabetes mellitus. Diabetes Care 1993; 16:1598-1605.
6. Hossein-nezhad A, Mirzaei k, Maghbooli Z, Larijani B. Maternal glycemic status in GDM patients after delivery. Iranian Journal of Diabetes and Lipid Disorders 2009; 8: 95-104.
7. Maghbooli, Z., Hossein-Nezhad, A., Rahmani, M. Relationship between leptin concentration and insulin resistance. Horm Metab Res 2007; 39:903-907.
8. Trayhurn, P., Wood, S.I., Adipokines: inflammation and the pleiotropic role of white adipose tissue. Brit J Nutr 2004; 92:347-355.
9. Maghbooli Z, Hossein-Nezhad A, Mirzaei K, Karimi F, Besharati A, Omidfar K, Larijani B. Association between Retinol-Binding Protein 4 concentrations and gestational diabetes mellitus and risk of developing metabolic syndrome after pregnancy. Reprod Sci 2009 Nov 6. [Epub ahead of print].
10. Kadowaki, T., Yamauchi, T., Kubota, N., Hara, K.,Ueki, K.,Tobe, K., Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006; 116:1784-1792.
11. Fukuhara, A., Matsuda, M., Nishizawa. Et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005; 307:426-430.
12. Kusminski, C.M., McTernan, P.G., Kumar, S. Role of resistin in obesity, insulin resistance and Type II diabetes. Clin Sci (Lond) 2005; 109:243-256.
13. Chandran, M., Phillips, S.A., Ciaraldi, T., Henry, R.R., Adiponectin: more than just another fat hormone? Diabetes Care 2003; 26:2442-2450.
14. Kumada, M., Kihara, S., Sumitsuji, S. et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003; 23:85-89.
15. Wolf, A.M., Wolf, D., Rumpold, H., Enrich, B., Tilg, H. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun 2004; 323:630-635.
16. Ouchi, N., Kobayashi, H., Kihara, S., Kumada, M.,Sato, K., Inoue, T., Funahashi, T., Walsh, K. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 2004; 279:1304-1309. (Pubitemid 38082655)
17. Worda, C., Leipold, H., Gruber, C., Kautzky-Willer, A.,Knofler, M., Bancher-Todesca, D. Decreased plasma adiponectin concentrations in women with gestational diabetes mellitus. Am J Obstet Gynecol 2004; 191:2120-2124.
18. Retnakaran, R., Hanley, A.J., Raif, N., Connelly, P.W., Sermer, M., Zinman, B. Hypoadiponectinaemia in South Asian women during pregnancy: evidence of ethnic variation in adiponectin concentration. Diabet Med 2004; 21:388-392.
19. Fonseca-Alaniz, M.H., Takada, J., Alonso-Vale, M.I., Lima, F.B. Adipose tissue as an endocrine organ: from theory to practice. J Pediatr (Rio J) 2007; 83:S192-203.
20. Mazaki-Tovi, S., Romero, R., Kusanovic, J.P. et al. Visfatin in human pregnancy: maternal gestational diabetes vis-à-vis neonatal birthweight. J Perinat Med, 2008, Dec 19. [Epub ahead of print].
21. Fasshauer, M., Blüher, M., Stumvoll, M., Tönessen, P., Faber, R., Stepan, H., Differential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function, Clin. Endocrinol. (Oxf.) 2007; 66: 434-443.
22. Krzyzanowska, K., Krugluger, W., Mittermayer, F. et al. Increased visfatin concentrations in women with gestational diabetes mellitus. Clin Sci (Lond) 2006; 110:605-609.
23. Steppan, C.M., Lazar, M.A. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab 2002; 13: 18-23.
24. Sagawa, N., Yura, S., Itoh, H., Mise, H., Kakui, K., Korita, D., Takemura, M., Nuamah, M.A., Ogawa, Y., Masuzaki, H., Nakao, K., Fuii, S. Role of leptin in pregnancy - a review. Placenta 2002; 23: S80-S86.
25. Chen, D., Dong, M., Fang, Q., He, J., Wang, Z., Yang, X. Alterations of serum resistin in normal pregnancy and pre-eclampsia. Clin Sci 2005; 108: 81-84.
26. Palik, E., Baranyi, E., Melczer, Z., Audkovsky, M., Szöcs, A., Winkler, G., Cseh, K., Elevated serum acylated (biologically active) ghrelin and resistin levels associate with pregnancy-induced weight gain and insulin resistance. Diabetes Res Clin Pract 2007; 76: 351-357.
27. Bentley-Lewis, R., Levkoff, S., Stuebe, A., Seely, E.W. Gestational diabetes mellitus: postpartum opportunities for the diagnosis and prevention of type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab 2008; 4:552-558.
28. Strehlow, S.L., Mestman, J.H., Prevention of T2DM in women with a previous history of GDM. Curr Diab Rep 2005; 5:272-277.
29. Hossein-Nezhad A., Maghbooli Z.h, Larijani B. The incidence of diabetes and abnormal glucose tolerance in women at early postpartum with previous gestational diabetes. Iranian Journal of Diabetes and Lipid Disorders 2004; 4: 27-34.
30. O'Sullivan, J.B., Mahan, C.M., Charles, D., Dandrow, R. Screening criteria for high-risk gestational diabetic patients. Am J Obstet Gynecol 1973; 116: 895-900.
31. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004; 27(Suppl 1): S5-S10.
32. World Health Organization, Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus, Geneva: WHO; 1999.
33. van Dielen, F.M., van't Veer, C., Schols, A.M., Soeters, P.B., Buurman, W.A., Greve, J.W., Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals. Int J Obes Relat Metab Disord 2001; 25:1759-1766.
34. Choi, S.H., Kwak, S.H., Youn, B.S. et al. High plasma retinol binding protein-4 and low plasma adiponectin concentrations are associated with severity of glucose intolerance in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab 2008; 93:3142-3148.
35. Megia A., Vendrell J., Gutierrez C., Sabaté M., Broch M., Fernández-Real J.M., Simón I. Insulin sensitivity and resistin levels in gestational diabetes mellitus and after parturition. Eur J Endocrinol 2008; 158: 173-178.
36. Akturk, M., Altinova, A.E., Mert, I., Buyukkagnici, U., Sargin, A., Arslan, M., Danisman, N. Visfatin concentration is decreased in women with gestational diabetes mellitus in the third trimester. J Endocrinol Invest 2008; 31:610-613.
37. Telejko B., Kuzmicki M., Zonenberg A., Szamatowicz J., Wawrusiewicz-Kurylonek N., Nikolajuk A., Kretowski A., Gorska M. Visfatin in gestational diabetes: Serum level and mRNA expression in fat and placental tissue. Diabetes Res Clin Pract 2009; 29.
38. Ognjanovic, S., Bryant-Greenwood, G.D. Pre-B-cell colony-enhancing factor, a novel cytokine of human fetal membranes. Am J Obstet Gynecol 2002; 187:1051-1058.
39. Antuna-Puente, B., Feve B., Fellahi, S., Bastard, J.P. Adipokines: The missing link between insulin resistance and obesity. Diabetes & Metabolism 2008; 34: 2-11.
40. Steppan, C.M.,Bailey, S.T., Bhat, S. et al. The hormone resistin links obesity to diabetes. Nature 2001; 409:307-312.
41. Vitoratos N., Deliveliotou A., Vlahos N.F. et al. Serum adiponectin during pregnancy and postpartum in women with gestational diabetes and normal controls. Gynecol Endocrinol 2008; 24:614-9.
42. Winzer C., Wagner O., Festa A. et al. Plasma Adiponectin, Insulin Sensitivity, and Subclinical Inflammation in Women with Prior Gestational Diabetes Mellitus. Diabetes Care 2004; 27:1721-1727.